Study of Lenalidomide/Ixazomib/Dexamethasone/Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed MM

NCT04009109 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

79

Enrollment

OTHER

Sponsor class

Conditions

Myeloma, Multiple

Interventions

DRUG: Lenalidomide
DRUG: Ixazomib
DRUG: Daratumumab Injection
DRUG: Dexamethasone

Sponsor

Alliance Foundation Trials, LLC.

Collaborators

[object Object]
[object Object]
[object Object]